Want to see IN:TARSONS full AI Analyst Report?
TARSONS Stock Chart & Stats
₹312.55
₹8.15(2.61%)
At close: 4:00 PM EDT
₹312.55
₹8.15(2.61%)
Day’s Range― - ―
52-Week Range₹164.15 - ₹374.40
Previous CloseN/A
Volume208.60K
Average Volume (3M)2.32K
Market Cap
₹18.42B
Enterprise Value₹19.86K
Total Cash (Recent Filing)₹252.56M
Total Debt (Recent Filing)₹3.93B
Price to Earnings (P/E)165.3
Beta0.90
Next Earnings
Nov 06, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)2.70
Shares Outstanding53,206,280
10 Day Avg. Volume1,556
30 Day Avg. Volume2,322
Financial Highlights & Ratios
PEG Ratio-1.29
Price to Book (P/B)1.51
Price to Sales (P/S)2.27
P/FCF Ratio-134.83
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)11.7
Revenue Forecast (FY)₹4.88B
Bulls Say, Bears Say
Bulls Say
Recurring Consumables DemandTarsons serves recurring laboratory workflows where consumables must be replenished regularly. This repeat-purchase model can support durable demand, improve customer retention, and provide a foundation for cross-selling its wider labware portfolio.
Resumed Revenue GrowthThe return to moderate revenue growth indicates that demand has recovered from the prior slowdown. Continued expansion across diagnostics, research, healthcare, and industrial laboratories could provide a durable base for future operating leverage.
Positive Operating Cash FlowPositive and improving operating cash flow shows that the core business is generating internal liquidity despite earnings pressure. This supports ongoing operations and gives management some capacity to fund production, inventory, and strategic investment.
Bears Say
Weakening ProfitabilityThe sharp decline in earnings and lower operating profit indicate that revenue growth is not translating into sustainable profitability. Persistent margin pressure could limit reinvestment capacity and reduce the benefits of scale across the product portfolio.
Rising LeverageMeaningfully higher debt increases financial risk while returns on equity have compressed. If profitability remains weak, additional interest and repayment obligations could constrain flexibility and make expansion more dependent on external funding.
Persistent Negative Free Cash FlowSustained negative free cash flow suggests that reinvestment or capital spending has exceeded internally generated cash. Unless conversion improves, the company may need debt or other funding to support growth, increasing balance-sheet and execution risk.
Tarsons Products Limited News
TARSONS FAQ
What was Tarsons Products Limited’s price range in the past 12 months?
Tarsons Products Limited lowest stock price was ₹164.15 and its highest was ₹374.40 in the past 12 months.
What is Tarsons Products Limited’s market cap?
Tarsons Products Limited’s market cap is ₹18.42B.
When is Tarsons Products Limited’s upcoming earnings report date?
Tarsons Products Limited’s upcoming earnings report date is Nov 06, 2026 which is in 72 days.
How were Tarsons Products Limited’s earnings last quarter?
Tarsons Products Limited released its earnings results on Aug 10, 2026. The company reported -₹0.271 earnings per share for the quarter, missing the consensus estimate of N/A by N/A.
Is Tarsons Products Limited overvalued?
According to Wall Street analysts Tarsons Products Limited’s price is currently Overvalued.
Does Tarsons Products Limited pay dividends?
Tarsons Products Limited pays a Notavailable dividend of ₹2 which represents an annual dividend yield of N/A. See more information on Tarsons Products Limited dividends here
What is Tarsons Products Limited’s EPS estimate?
Tarsons Products Limited’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Tarsons Products Limited have?
Tarsons Products Limited has 53,206,280 shares outstanding.
What happened to Tarsons Products Limited’s price movement after its last earnings report?
Tarsons Products Limited reported an EPS of -₹0.271 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went up 0.016%.
Which hedge fund is a major shareholder of Tarsons Products Limited?
Currently, no hedge funds are holding shares in IN:TARSONS
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Tarsons Products Limited
Established in 1983 and headquartered in Kolkata, India, Tarsons Products Limited specializes in the global manufacturing and distribution of plastic laboratory supplies and scientific instruments. The company's diverse product portfolio features disposable plastic labware, centrifuge and cryogenic equipment, liquid handling systems, and safety products. Its comprehensive catalog further encompasses items such as bottles, carboys, measuring cylinders, cell culture products, electrophoresis apparatus, microscopy and microbiology tools, vacuum desiccators, mini coolers, cryo boxes, beakers, test tube racks, pipette tips, petri dishes, centrifuge tubes, cryogenic and storage vials, Pasteur pipettes, and vortex mixers, among many others. These offerings are vital for research and applications across various scientific disciplines including molecular biology, cell culture, genomics, proteomics, and immunology.
Technical Analysis
Krebs Biochemicals & Industries Ltd.
―
Poly Medicure Limited
―
Vimta Labs Limited
―
Zim Laboratories Ltd.
―
Fischer Medical Ventures Ltd
―